What is James Stoever's NPI number?

James Stoever's National Provider Identifier (NPI) is 1679515894, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is James Stoever's specialty?

James Stoever is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).

Where is James Stoever located?

James Stoever's practice location on file with NPPES is 705 E 70th St, Savannah, GA 31405-4810.

What is James Stoever's phone number?

The practice phone number listed in the NPPES registry for James Stoever is (912) 354-7622.

Does James Stoever accept Medicare?

James Stoever is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is James Stoever's NPI active?

Yes — James Stoever's NPI (1679515894) is active in the NPPES registry as of the last update on 2012-08-29.

IndividualActiveAccepts Medicare

James Stoever, D.O.

NPI 1679515894 · Endocrinology, Diabetes & Metabolism Physician · Savannah, GA

James Stoever, D.O. is a Endocrinology, Diabetes & Metabolism Physician provider in Savannah, GA (NPI 1679515894).

Provider details

NPI number: 1679515894
Entity type: Individual
Primary specialty: Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
Credential: D.O.
Sex: Male
Sole proprietor: Yes
License: 048308 (GA)

Practice location

705 E 70th St

Savannah, GA 31405-4810

Phone: (912) 354-7622

Fax: (912) 354-7783

Street-level locationGet directions

More GA providers

Mailing address

705 E 70th St

Savannah, GA 31405-4810

Specialties & taxonomies

Endocrinology, Diabetes & Metabolism PhysicianPrimary207RE0101XLicense 048308 (GA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,284 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	1,214	$122
Blood Glucose (sugar) Test Performed By Hand-Held Instrument82962	789	$3
Continuous Monitoring of Blood Sugar Level in Tissue Fluid Using Sensor Under Skin With Interpretation and Report95251	405	$33
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	310	$86
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	286	$16

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 93 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Levothyroxine Sodium	906	243
Levothyroxine Sodiumbrand: Synthroid	604	134
Insulin Glargine,hum.rec.anlogbrand: Lantus Solostar	367	112
Tirzepatidebrand: Mounjaro	334	61
Dapagliflozin Propanediolbrand: Farxiga	301	65
Empagliflozinbrand: Jardiance

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$69 across 2 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-06-12
Last updated: 2012-08-29

Frequently asked questions

What is James Stoever's NPI number?: James Stoever's National Provider Identifier (NPI) is 1679515894, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is James Stoever's specialty?: James Stoever is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
Where is James Stoever located?: James Stoever's practice location on file with NPPES is 705 E 70th St, Savannah, GA 31405-4810.
What is James Stoever's phone number?: The practice phone number listed in the NPPES registry for James Stoever is (912) 354-7622.
Does James Stoever accept Medicare?: James Stoever is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is James Stoever's NPI active?: Yes — James Stoever's NPI (1679515894) is active in the NPPES registry as of the last update on 2012-08-29.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	1,214	$122
Blood Glucose (sugar) Test Performed By Hand-Held Instrument82962	789	$3
Continuous Monitoring of Blood Sugar Level in Tissue Fluid Using Sensor Under Skin With Interpretation and Report95251	405	$33
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	310	$86
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	286	$16

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 93 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Levothyroxine Sodium	906	243
Levothyroxine Sodiumbrand: Synthroid	604	134
Insulin Glargine,hum.rec.anlogbrand: Lantus Solostar	367	112
Tirzepatidebrand: Mounjaro	334	61
Dapagliflozin Propanediolbrand: Farxiga	301	65
Empagliflozinbrand: Jardiance

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$69 across 2 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments